The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022.

Comerford C, Hayden PJ, Eikema DJ, Koster L, Sauer S, Broers A, Rabin N, Bastie JN, Gedde-Dahl T, Giaccone L, Richardson D, Carlson K, Besemer B, de Colella JS, Zeiser R, Vincent L, Pabst T, Cairoli A, Schuermans C, Poiani M, Raj K, Drozd-Sokolowska J, Garderet L, Najjar IE, Beksac M, McLornan DP

Open source

DOI: 10.1111/bjh.70759
Published: 2026 Aug 19
Container: British journal of haematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70759,
  title = {The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022.},
  author = {Comerford C and Hayden PJ and Eikema DJ and Koster L and Sauer S and Broers A and Rabin N and Bastie JN and Gedde-Dahl T and Giaccone L and Richardson D and Carlson K and Besemer B and de Colella JS and Zeiser R and Vincent L and Pabst T and Cairoli A and Schuermans C and Poiani M and Raj K and Drozd-Sokolowska J and Garderet L and Najjar IE and Beksac M and McLornan DP},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70759},
  url = {https://doi.org/10.1111/bjh.70759}
}

RIS

TY  - JOUR
TI  - The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022.
AU  - Comerford C
AU  - Hayden PJ
AU  - Eikema DJ
AU  - Koster L
AU  - Sauer S
AU  - Broers A
AU  - Rabin N
AU  - Bastie JN
AU  - Gedde-Dahl T
AU  - Giaccone L
AU  - Richardson D
AU  - Carlson K
AU  - Besemer B
AU  - de Colella JS
AU  - Zeiser R
AU  - Vincent L
AU  - Pabst T
AU  - Cairoli A
AU  - Schuermans C
AU  - Poiani M
AU  - Raj K
AU  - Drozd-Sokolowska J
AU  - Garderet L
AU  - Najjar IE
AU  - Beksac M
AU  - McLornan DP
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70759
UR  - https://doi.org/10.1111/bjh.70759
ER  -

APA

C, C., PJ, H., DJ, E., L, K., S, S., A, B., N, R., JN, B., T, G., L, G., D, R., K, C., B, B., JS, D. C., R, Z., L, V., T, P., A, C., C, S., M, P., K, R., J, D., L, G., IE, N., M, B., & DP, M. (2026). The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022.. British journal of haematology. https://doi.org/10.1111/bjh.70759

Source records

pubmed · retrieved 2026-09-26T18:13:49.615Z